STEK
Stemtech Corporation
Price Chart
Latest Quote
$0.00
+0.00 (+100.00%)
Current Price
| Previous Close | $0.00 |
| Open | $0.00 |
| Day High | $0.00 |
| Day Low | $0.00 |
| Volume | 30,830,041 |
Stock Information
| Shares Outstanding | 2.07B |
| Total Debt | $5.01M |
| Cash Equivalents | $238K |
| Revenue | $2.88M |
| Net Income | $-4.05M |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Market Cap | $414K |
| EPS (TTM) | $-0.02 |
| Exchange | PNK |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $4.43M |
| Sales | $2.88M |
| Income | $-4.05M |
| Book/sh | $-0.02 |
| Cash/sh | $0.00 |
Financial Ratios
| Quick Ratio | 0.02 |
| Current Ratio | 0.04 |
Returns & Margins
| ROA | -48.85% |
| Gross Margin | 80.29% |
| Operating Margin | -188.59% |
| Profit Margin | -140.69% |
Ownership
| Insider Ownership | 12.02% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| P/S | 0.14 |
| P/B | -0.01 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $0.00 |
| SMA50 | $0.00 |
| SMA200 | $0.00 |
| RSI | 57.35 |
| ATR | 0.0001 |
| Shares Float | 2.02B |
| Volatility | 2.52 |
| Rel Volume | 0.23 |
Performance History
| Week | +0.00% |
| Month | +0.00% |
| Quarter | -20.00% |
| 6 Months | -88.24% |
| YTD | -77.78% |
| Year | -99.37% |
| 3 Years | -99.64% |
| 10 Years | -99.99% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-12 | $0.00 | 3,399,426 |
| 2026-06-11 | $0.00 | 2,442,186 |
| 2026-06-10 | $0.00 | 1,108,001 |
| 2026-06-09 | $0.00 | 452,313 |
| 2026-06-08 | $0.00 | 545,084 |
| 2026-06-05 | $0.00 | 389,944 |
| 2026-06-04 | $0.00 | 54,291,242 |
| 2026-06-03 | $0.00 | 52,047,347 |
| 2026-06-02 | $0.00 | 3,629,510 |
| 2026-06-01 | $0.00 | 643,737 |
| 2026-05-29 | $0.00 | 1,896,241 |
| 2026-05-28 | $0.00 | 52,508,204 |
| 2026-05-27 | $0.00 | 52,135,981 |
| 2026-05-26 | $0.00 | 1,636,869 |
| 2026-05-22 | $0.00 | 1,870,263 |
| 2026-05-21 | $0.00 | 23,787,086 |
| 2026-05-20 | $0.00 | 4,371,144 |
| 2026-05-19 | $0.00 | 781,100 |
| 2026-05-18 | $0.00 | 32,799,183 |
| 2026-05-15 | $0.00 | 4,929,991 |
| 2026-05-14 | $0.00 | 40,412,800 |
| 2026-05-13 | $0.00 | 4,514,854 |
About Stemtech Corporation
Stemtech Corporation, a stem cell nutrition company, develops science-based products to help the body maintain healthy stem cell physiology in the Americas, Latin America, and Asia. The company's products enhance and support the work of the body's stem cells by releasing more stem cells, helping to circulate them in the blood, and migrate them into tissues, where they can perform their daily function of renewal for optimal health. It offers rapid renewed stem cell peptide night cream under the RCM System, stemrelease3, Stemflo MigraStem, OraStem, and Collect One brand name, as well as Cellect One shield hypochlorous acid skin care product. It sells products through independent distributors. Stemtech Corporation was founded in 2005 and is headquartered in Naples, Florida.
đ° Latest News
No news articles available at the moment. Check back later for updates on STEK.
Period:
Loading...
Income Statement (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $1,326,344 | $1,001,640 | $1,164,018 | $1,023,160 |
| Cost Of Revenue | $1,326,344 | $1,001,640 | $1,164,018 | $1,023,160 |
| Total Revenue | $5,053,690 | $4,921,531 | $4,559,399 | $4,321,245 |
| Operating Revenue | $5,053,690 | $4,921,531 | $4,559,399 | $4,321,245 |
| Expenses | ||||
| Interest Expense | $1,579,370 | $4,893,033 | $4,097,843 | $8,330,201 |
| Total Expenses | $7,440,117 | $9,146,079 | $9,582,779 | $7,531,516 |
| Other Income Expense | $193,096 | $3,685,600 | $584,013 | $4,429,363 |
| Other Non Operating Income Expenses | $85,363 | $16,484 | $7,928 | $-124,009 |
| Net Non Operating Interest Income Expense | $-1,579,370 | $-4,893,033 | $-4,097,843 | $-8,330,201 |
| Interest Expense Non Operating | $1,579,370 | $4,893,033 | $4,097,843 | $8,330,201 |
| Operating Expense | $6,113,773 | $8,144,439 | $8,418,761 | $6,508,356 |
| Other Operating Expenses | $780,772 | $1,187,027 | $1,047,400 | - |
| Selling And Marketing Expense | $99,178 | $504,075 | $533,397 | $1,754,576 |
| General And Administrative Expense | $5,233,823 | $6,439,537 | $6,837,964 | $4,753,780 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-3,769,566 | $-5,430,245 | $-8,544,923 | $-7,077,463 |
| Net Interest Income | $-1,579,370 | $-4,893,033 | $-4,097,843 | $-8,330,201 |
| Normalized Income | $-3,877,299 | $-9,099,361 | $-9,000,030 | $-11,630,835 |
| Net Income From Continuing And Discontinued Operation | $-3,769,566 | $-5,430,245 | $-8,544,923 | $-7,077,463 |
| Total Operating Income As Reported | $-2,386,427 | $-4,224,548 | $-5,023,380 | $-3,210,271 |
| Net Income Common Stockholders | $-3,769,566 | $-5,430,245 | $-8,544,923 | $-7,077,463 |
| Net Income | $-3,769,566 | $-5,430,245 | $-8,544,923 | $-7,077,463 |
| Net Income Including Noncontrolling Interests | $-3,772,701 | $-5,431,979 | $-8,632,828 | $-7,111,109 |
| Net Income Continuous Operations | $-3,772,701 | $-5,431,979 | $-8,632,828 | $-7,111,109 |
| Pretax Income | $-3,772,701 | $-5,431,979 | $-8,537,210 | $-7,111,109 |
| Special Income Charges | $107,733 | $814,132 | $3,799,356 | $0 |
| Operating Income | $-2,386,427 | $-4,224,548 | $-5,023,380 | $-3,210,271 |
| Gross Profit | $3,727,346 | $3,919,891 | $3,395,381 | $3,298,085 |
| Per Share | ||||
| Diluted EPS | $-0.03 | $-0.07 | $-0.19 | $-0.20 |
| Basic EPS | $-0.03 | $-0.07 | $-0.19 | $-0.20 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $120,978 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-1,885,778 | $-3,548,284 | $-4,568,066 | $-2,905,694 |
| Total Unusual Items | $107,733 | $3,669,116 | $576,085 | $4,553,372 |
| Total Unusual Items Excluding Goodwill | $107,733 | $3,669,116 | $576,085 | $4,553,372 |
| Reconciled Depreciation | $415,286 | $659,778 | $447,386 | $428,586 |
| EBITDA (Bullshit earnings) | $-1,778,045 | $120,832 | $-3,991,981 | $1,647,678 |
| EBIT | $-2,193,331 | $-538,946 | $-4,439,367 | $1,219,092 |
| Diluted Average Shares | $118,697,641 | $83,469,544 | $46,014,138 | $35,311,381 |
| Basic Average Shares | $118,697,641 | $83,469,544 | $46,014,138 | $35,311,381 |
| Diluted NI Availto Com Stockholders | $-3,769,566 | $-5,430,245 | $-8,544,923 | $-7,077,463 |
| Minority Interests | $3,135 | $1,734 | $87,905 | $33,646 |
| Tax Provision | $0 | $0 | $95,618 | $0 |
| Gain On Sale Of Ppe | $0 | $0 | - | $0 |
| Other Special Charges | $-107,733 | $-814,132 | $-3,799,356 | - |
| Research And Development | $0 | $13,800 | $0 | $0 |
| Selling General And Administration | $5,333,001 | $6,943,612 | $7,371,361 | $6,508,356 |
| Other Gand A | $5,233,823 | $6,439,537 | $6,837,964 | $4,753,780 |
| Gain On Sale Of Security | - | $2,854,984 | $-3,223,271 | $4,553,372 |
| Salaries And Wages | - | - | - | $1,014,721 |
Fetched: 2026-02-02
Balance Sheet (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $-7,327,743 | $-5,217,249 | $-5,895,568 | $-7,229,715 |
| Total Assets | $3,782,245 | $3,683,271 | $4,266,941 | $5,720,122 |
| Total Non Current Assets | $2,860,498 | $3,282,561 | $3,654,571 | $4,120,083 |
| Non Current Prepaid Assets | $16,932 | $23,708 | $23,065 | $38,692 |
| Goodwill And Other Intangible Assets | $2,843,566 | $3,177,977 | $3,461,409 | $3,874,123 |
| Other Intangible Assets | $2,376,157 | $2,710,568 | $2,994,000 | $3,406,714 |
| Current Assets | $921,746 | $400,710 | $612,370 | $1,600,039 |
| Other Current Assets | $199,344 | $176,725 | $287,063 | $324,708 |
| Inventory | $197,355 | $48,325 | $158,053 | $436,405 |
| Receivables | $269,749 | $61,494 | $34,767 | $10,720 |
| Accounts Receivable | $269,749 | $61,494 | $34,767 | $10,720 |
| Cash Cash Equivalents And Short Term Investments | $255,298 | $114,166 | $132,487 | $828,206 |
| Cash And Cash Equivalents | $255,298 | $114,166 | $132,487 | $828,206 |
| Cash Financial | $255,298 | $114,166 | $132,487 | $828,206 |
| Prepaid Assets | - | - | - | $324,708 |
| Debt | ||||
| Net Debt | $3,560,286 | $3,372,115 | $796,644 | $447,169 |
| Total Debt | $3,815,584 | $3,553,147 | $1,071,264 | $1,450,185 |
| Long Term Debt And Capital Lease Obligation | $0 | $0 | $23,068 | $338,530 |
| Current Debt And Capital Lease Obligation | $3,815,584 | $3,553,147 | $1,048,196 | $1,111,655 |
| Current Debt | $3,815,584 | $3,486,281 | $929,131 | $1,055,910 |
| Other Current Borrowings | $1,769,583 | $1,596,960 | $482,885 | $602,787 |
| Long Term Debt | - | - | - | $219,465 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $9,009,050 | $6,462,036 | $7,438,859 | $9,725,568 |
| Total Non Current Liabilities Net Minority Interest | $1 | $0 | $23,068 | $338,530 |
| Other Non Current Liabilities | $1 | - | - | - |
| Current Liabilities | $9,009,049 | $6,462,036 | $7,415,791 | $9,387,038 |
| Other Current Liabilities | $673,611 | $143,944 | $2,931,882 | $4,224,585 |
| Current Deferred Liabilities | $1,463 | $56,039 | $39,170 | $0 |
| Current Notes Payable | $2,046,001 | $1,889,321 | $296,246 | $303,123 |
| Payables And Accrued Expenses | $4,518,391 | $2,708,906 | $3,396,543 | $4,050,798 |
| Payables | $4,518,391 | $2,708,906 | $3,396,543 | $4,050,798 |
| Accounts Payable | $4,518,391 | $2,708,906 | $3,396,543 | $4,050,798 |
| Equity | ||||
| Common Stock Equity | $-4,484,177 | $-2,039,272 | $-2,434,159 | $-3,355,592 |
| Total Equity Gross Minority Interest | $-5,226,805 | $-2,778,765 | $-3,171,918 | $-4,005,446 |
| Stockholders Equity | $-4,484,177 | $-2,039,272 | $-2,434,159 | $-3,355,592 |
| Gains Losses Not Affecting Retained Earnings | $-146,277 | $190,503 | $-247,760 | $-430,255 |
| Other Equity Adjustments | $-146,277 | $190,503 | $-247,760 | $-430,255 |
| Retained Earnings | $-30,831,052 | $-27,061,486 | $-21,631,241 | $-13,086,318 |
| Other | ||||
| Ordinary Shares Number | $135,756,053 | $104,988,853 | $53,442,147 | $44,685,673 |
| Share Issued | $135,756,053 | $104,988,853 | $53,442,147 | $44,685,673 |
| Tangible Book Value | $-7,327,743 | $-5,217,249 | $-5,895,568 | $-7,229,715 |
| Invested Capital | $-668,593 | $1,447,009 | $-1,505,028 | $-2,080,217 |
| Working Capital | $-8,087,303 | $-6,061,326 | $-6,803,421 | $-7,786,999 |
| Capital Lease Obligations | $0 | $66,866 | $142,133 | $174,810 |
| Total Capitalization | $-4,484,177 | $-2,039,272 | $-2,434,159 | $-3,136,127 |
| Minority Interest | $-742,628 | $-739,493 | $-737,759 | $-649,854 |
| Additional Paid In Capital | $26,357,396 | $24,726,722 | $19,391,400 | $10,116,296 |
| Capital Stock | $135,756 | $104,989 | $53,442 | $44,685 |
| Common Stock | $135,756 | $104,989 | $53,442 | $44,685 |
| Long Term Capital Lease Obligation | $0 | $0 | $23,068 | $119,065 |
| Current Deferred Revenue | $1,463 | $56,039 | $39,170 | $0 |
| Current Capital Lease Obligation | $0 | $66,866 | $119,065 | $55,745 |
| Duefrom Related Parties Non Current | $0 | $0 | - | - |
| Goodwill | $467,409 | $467,409 | $467,409 | $467,409 |
| Net PPE | $0 | $80,876 | $170,097 | $207,268 |
| Gross PPE | $0 | $80,876 | $170,097 | $207,268 |
| Finished Goods | $197,355 | $48,325 | $103,297 | $249,659 |
| Raw Materials | $0 | $0 | $54,756 | $186,746 |
| Line Of Credit | - | $0 | $150,000 | $150,000 |
| Other Properties | - | $80,876 | $170,097 | $207,268 |
| Accumulated Depreciation | - | - | - | $-233,736 |
| Machinery Furniture Equipment | - | - | - | $266,904 |
Fetched: 2026-02-02
Cash Flow Statement (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-601,198 | $-2,036,012 | $-1,216,948 | $-1,914,093 |
| Operating Activities | ||||
| Operating Cash Flow | $-601,198 | $-2,036,012 | $-1,216,948 | $-1,914,093 |
| Cash Flow From Continuing Operating Activities | $-601,198 | $-2,036,012 | $-1,216,948 | $-2,013,252 |
| Operating Gains Losses | $-107,733 | $-3,669,116 | $-576,085 | $-4,553,372 |
| Investing Activities | ||||
| Investing Cash Flow | $0 | $0 | - | $0 |
| Cash Flow From Continuing Investing Activities | $0 | $0 | - | $0 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $474,812 | $0 | $100,002 | $0 |
| Financing Cash Flow | $1,079,110 | $1,579,428 | $338,734 | $2,628,739 |
| Cash Flow From Continuing Financing Activities | $1,079,110 | $1,579,428 | $338,734 | $2,628,739 |
| Net Other Financing Charges | $529,667 | $-189,700 | $214,249 | - |
| Net Common Stock Issuance | $474,812 | $0 | $100,002 | $0 |
| Common Stock Issuance | $474,812 | $0 | $100,002 | $0 |
| Other | ||||
| Repayment Of Debt | $-282,034 | $-466,872 | $-586,783 | $-693,230 |
| Issuance Of Debt | $356,665 | $2,236,000 | $611,266 | $3,321,969 |
| Interest Paid Supplemental Data | $6,821 | $6,821 | $36,205 | $11,389 |
| Income Tax Paid Supplemental Data | $0 | $0 | $0 | $0 |
| End Cash Position | $255,298 | $114,166 | $132,487 | $828,206 |
| Beginning Cash Position | $114,166 | $132,487 | $828,206 | $133,065 |
| Effect Of Exchange Rate Changes | $-336,780 | $438,263 | $182,495 | $-19,505 |
| Changes In Cash | $477,912 | $-456,584 | $-878,214 | $714,646 |
| Net Issuance Payments Of Debt | $74,631 | $1,769,128 | $24,483 | $2,628,739 |
| Net Long Term Debt Issuance | $74,631 | $1,769,128 | $24,483 | $2,628,739 |
| Long Term Debt Payments | $-282,034 | $-466,872 | $-586,783 | $-693,230 |
| Long Term Debt Issuance | $356,665 | $2,236,000 | $611,266 | $3,321,969 |
| Net PPE Purchase And Sale | $0 | $0 | - | $0 |
| Sale Of PPE | $0 | $0 | - | - |
| Change In Working Capital | $1,381,782 | $1,091,354 | $-337,689 | $874,269 |
| Change In Other Working Capital | $-54,576 | $16,869 | $39,170 | - |
| Change In Other Current Liabilities | $0 | $-75,267 | $-1,378 | $99,159 |
| Change In Payables And Accrued Expense | $1,809,486 | $957,056 | $-683,058 | $1,217,832 |
| Change In Payable | $1,809,486 | $957,056 | $-683,058 | $1,217,832 |
| Change In Account Payable | $1,809,486 | $957,056 | $-683,058 | $1,217,832 |
| Change In Prepaid Assets | $-15,843 | $109,695 | $53,272 | $-128,940 |
| Change In Inventory | $-149,030 | $109,728 | $278,352 | $-237,778 |
| Change In Receivables | $-208,255 | $-26,727 | $-24,047 | $15,102 |
| Changes In Account Receivables | $-208,255 | $-26,727 | $-24,047 | $15,102 |
| Other Non Cash Items | $1,041,912 | $4,874,897 | $3,886,081 | $7,416,360 |
| Stock Based Compensation | $440,256 | $439,054 | $3,996,187 | $1,031,173 |
| Depreciation Amortization Depletion | $415,286 | $659,778 | $447,386 | $428,586 |
| Depreciation And Amortization | $415,286 | $659,778 | $447,386 | $428,586 |
| Depreciation | $415,286 | $659,778 | $447,386 | $326,261 |
| Net Income From Continuing Operations | $-3,772,701 | $-5,431,979 | $-8,632,828 | $-7,111,109 |
| Net Short Term Debt Issuance | - | $1,769,128 | $24,483 | - |
| Short Term Debt Payments | - | $-466,872 | $-586,783 | - |
| Short Term Debt Issuance | - | $2,236,000 | $611,266 | - |
| Gain Loss On Investment Securities | - | $-2,854,984 | $3,223,271 | $-4,553,372 |
| Change In Other Current Assets | - | - | $0 | $8,053 |
| Purchase Of PPE | - | - | - | $0 |
| Change In Accrued Expense | - | - | - | $0 |
Fetched: 2026-02-02